Validation Best Practices Jeb Bullis Senior Account Executive

Size: px
Start display at page:

Download "Validation Best Practices Jeb Bullis Senior Account Executive"

Transcription

1 Validation Best Practices Jeb Bullis Senior Account Executive

2 Today s Topics Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Validating Applications References Questions

3 Amadeus Mission: Compliance Process Control To enable our customers to manage, control, and change highly regulated processes and their associated content to reduce regulatory risk and sustain compliance over time. Processes WWW People Content

4 Agenda Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Validating Applications References Questions

5 Testing Activities in which a system or component is executed under specified conditions, the results are observed or recorded and an evaluation is made of some aspect of the system or component. (IEEE)

6 Verification Checking and reviewing project artifacts to ensure that the desired process was followed Confirmation through the provision of objective evidence that specified requirements have been fulfilled. (ISO) The process of evaluating a system or component to determine whether the system of a given development phase satisfies the conditions imposed at the start of that phase. (IEEE) Encompassing unit and integration testing

7 Validation Obtaining evidence and determining that the system actually functions as expected Establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes. (FDA) The process of evaluating a system or component during or at the end of the development process to determine whether a system or component satisfies specified requirements. (IEEE)

8 Verification vs. Validation Verification is set of activities to ensure that a function is developing properly ; Validation is a different set of activities to ensure that the function that has been built is working properly. (Verification) Are we producing the product right? (Validation) Are we producing the right product? -Boehm

9 Testing Levels The test phase of the validation life cycle ensures that the computerized system functions as expected and meets its intended use. The test phase is divided into the following four levels: Unit Testing Integration Testing System Testing (OQ) User Acceptance Testing (PQ)

10 Agenda Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Validating Applications References Questions

11 Regulatory Requirements Code of Federal Regulations, Title 21, Part 11, Electronic Records; Electronic Signatures General Principles of Software Validation; Final Guidance for Industry and FDA Staff, 11-Jan-2002 Guidance for Industry, Part 11, Electronic Records; Electronic Signatures Scope and Application, August 2003 Predicate Rules that may Apply to a Specific System Components of regulations that require regulated companies to provide information to the FDA or maintain information for review by the FDA For example, Part 820 Good Manufacturing Practice for management of SOPs

12 21 CFR Part 11 & Validation February Draft Guidance Part 11 incorporated in GMP Initiative at CDER Joe Famulare, made head of Part 11 Compliance Committee - FDA Part 11 Guidance for Industry Withdrawn!! Validation, Glossary ( 01); Maintenance ( 02); Elec. Copies ( 03) FDA s New Draft Part 11 Scope & Application Emphasis GAMP4 Guide & CDRH Principles of Software Validation Predicate Rule Requirements & Documented Risk Assessment FDA Final Guidance Timetable slipped into September Excerpts: PDA Vancouver Conference on Pharmaceutical Manufacturing

13 21 CFR Part 11 & Validation September Final Guidance Part 11 Remains in Effect Emphasized Joe Famulare reviewed Final Guidance at FDA/FDA DC Conf. FDA Part 11 Guidance will not be Reissued FDA s Final Part Part 11 Scope & Application Emphasis Joe Famulare noted this is NOT temporary; it s the approach GAMP4 Guide & CDRH Principles of Software Validation Predicate Rule Requirements & Documented Risk Assessment FDA Changes to Part 11 will take Years to enact Joe Famulare 6 mo. Public discussion prior to new rulemaking Excerpts: PDA Vancouver Conference on Pharmaceutical Manufacturing

14 What Should I Tell My Boss? It appears the FDA heard and heeded industry Past regulation by podium repudiated FDA to apply a narrower scope to enforcement Focus on the Predicate Rules, not on ALL electronic records created FDA s Final Part Part 11 Scope & Application Emphasis It is important that this new guidance not be overinterpreted to imply a relaxation of validation requirements [e.g. 21 CFR (i) reference] Excerpts: PDA Vancouver Conference on Pharmaceutical Manufacturing

15 Agenda Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Industry Trends Validating Documentum Applications References Questions

16 Projecting Compliance Across the Enterprise The quality system provides the foundation for the manufacturing systems that are linked and function within it... Page 6, Inspection Criteria; FDA CDER Draft Guidance for Industry, Sept. 2004

17 FDA Investigator Focal Points Review firm s predicate recordkeeping requirements and procedures for providing electronic and paper copies Review the overall security of electronic record-keeping Review Validation documentation Review firm s self-audit, corrective action plan and progress Training of IS and technical personnel Does the firm maintain a validated state?

18 Validation Overview 7 Phases Plan Analyze Design Construct Test Deploy Maintain Risk Assessment Validation Planning Vendor Assessment Training Planning Gather and Assess Requirements Determine Technical Architecture Determine System Design Configure Development Environment Configure and Develop Application Software Develop Installation Script or Instructions Unit Testing Integration Testing System Testing User Acceptance Testing Set Up and Qualify Production Environment Deliver Software to Client Workstations Migrate Legacy Data Train Users Issue Procedures Perform Validation Assessment Business Continuity Planning Disaster Recovery Planning System Administration Backup and Recovery Change Control Periodic Review On-going User Training Publish Release Memo

19 Risk Based Validation Approach We recommend that you base your approach on a justified and documented risk assessment, and a determination of the potential of the system to affect product quality and safety and record integrity. (21 CFR Part 11 Scope and Application 9/03/03)

20 Risk Based Assessment of Functionality Creating and importing documents (M) Editing content and properties (M) Searching for documents (H) Copying documents (M) Viewing documents (H) Printing documents Controlled (H) Uncontrolled (L) Reviewing & annotating documents (M) Approving documents (H) Processing To Be Read notifications (H) Making approved documents effective (H) Creating change requests (M) Reviewing & approving change requests (H) Obsoleting a document (H) Performing periodic review (H) Building document relationships (L) Exporting documents (L) Setting and enforcing security (H) Electronic signatures and records (H) Capturing and displaying audit trails (H)

21 Approach to Validation Based on Predicate Rules If the Amadeus eqcm ECM repository is used for managing quality SOPs and compliance processes Validate the use of SOPs because of the GMP predicate rule, 21 CFR Part 820. Validate the CAPA system because of GMP predicate rule, 21 CFR If there is no FDA predicate rule with respect to the type of documents to be validated, do not validate.

22 Agenda Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Validating Applications References Questions

23 When is a Computerized System Required to be Validated? It depends on your requirements and how you interpret the regulations under which your system will function Validation is typically required when the system: Affects product safety, identity, strength, efficacy, or quality Contains information that is: Submitted to, or provided for, a regulatory agency in accordance with the predicate rules Used to demonstrate compliance with government regulations Used by healthcare professionals to obtain a professional opinion that would influence the use of a product Provided to patients or the public to dictate the use of the product

24 What is a Validation Plan? A document, which describes the overall strategy and responsible parties for validating a system within its operating environment. (FDA) The FDA does not tell you how to validate a computerized system. The validation plan describes how you intend to validate the system. The FDA will hold you accountable for following the processes and developing the deliverables described in the project-specific validation plan.

25 What Happens if I did not Follow the Validation Plan? You must revise and re-approve the validation plan to reflect your actual processes, or You must document a project deviation, which summarizes the issue and rationale, and include it in the validation summary report.

26 How can I Validate a System that is already in Production? Take a retrospective validation approach Similar to validating an off-the-shelf product with little vendor knowledge Consider specific system circumstances (e.g. how long in production) and develop an appropriate validation plan Thoroughly document any assumptions in your validation plan

27 What Happened to the OQ & PQ Validation Phases? The FDA s General Principles of Software Validation states: While IQ/OQ/PQ terminology has served its purpose well and is one of many legitimate ways to organize software validation tasks at the user site, this terminology may not be well understood among many software professionals, and it is not used elsewhere in this document. Operational Qualification is equivalent to System Testing Performance Qualification is equivalent to User Acceptance Testing

28 What User Roles Participate in Validation Activities? Application Architecture Representative Auditing Lead Business/System Owner Business Process Lead Business Support Representative Change Request Approver Change Request Originator CIT Representative Developer Development Lead End-User Infrastructure Representative Project Manager Quality Assurance Lead Release Manager Subject Matter Expert System Administrator Technical Architect Technical Lead Technical Support Representative Testing Lead Training Lead Validation Analysts Validation Lead

29 What Validation Deliverables are Produced? Validation Master Plan Risk Assessment Report Vendor Assessment Report Training Plan User Requirements Specification System Requirements Specification Project Glossary Technical Architecture Specification Detailed Design Specifications Code Review Forms (only if customized) Unit, Integration, System and User Acceptance Test Plan Scripts Reports Test Incident Reports Validation Summary Report Data Migration Plan System Release Memo Change Request Form Periodic Review Report Business Continuity Plan Standard Operating Procedures Training Records

30 Agenda Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Validating Applications References Questions

31 Using a GAMP-4 Validation Methodology

32

33 Actionable Intelligence For Compliance

34 Actionable Compliance Intelligence Delivered

35 Agenda Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Validating Applications References Questions

36 References Code of Federal Regulations, Title 21, Part 11, Electronic Records; Electronic Signatures GAMP Guideline for the Validation of Automated Systems Version 4 (ISPE, 2001) General Principles of Software Validation; Final Guidance for Industry and FDA Staff, 11-Jan-2002 Guidance for Industry, Part 11, Electronic Records; Electronic Signatures Scope and Application, August 2003 IEEE Std , IEEE Standard for Software Project Management Plans IEEE Std , IEEE Standard for Software Verification and Validation, 9-Mar-1998 IEEE Std 1012a-1998, Supplement to IEEE Standard for Software Verification and Validation: Content Map to IEEE/EIA IEEE Std (R2002), IEEE Standard for Software Reviews IEEE Std (R2002), IEEE Standard Classification for Software Anomalies IEEE Std , IEEE Standard for Software User Documentation, 20- Dec-2001

37 References IEEE Std , IEEE Standard for Software Maintenance IEEE Std 1233,1998, IEEE Guide for Developing System Requirements Specifications, 8-Dec-1998 IEEE Std , IEEE Recommended Practice for Architectural Description of Software Intensive Systems IEEE Std (R2002), IEEE Standard Glossary of Software Engineering Terminology IEEE Std , IEEE Standard for Software Configuration Management Plans IEEE Std , IEEE Standard for Software Test Documentation IEEE Std 830,1998, IEEE Recommended Practice for Software Requirements Specifications, 25-Jun-1998 IEEE Std , IEEE Recommended Practice for Software Design Descriptions ISO 14971:2000(E), Medical Devices Application of Risk Management to Medical Devices, ISO, 2000.

38 Agenda Introduction Key Terms Regulatory Requirements Validation Overview Best Practice Responses to Frequently Asked Questions Validating Applications References Questions

39 Amadeus Solutions, Inc. Jeb Bullis Account Executive

40 Current Global Regulations BSI DISC PD MoReq Data Protection Act of :1999 CRFB - France Dublin Core SEC 17a-4 NASD 3010 FERC Part 125 UK Metadata Framework Sarbanes-Oxley Basel II Rev. Proc HIPAA SEC 17a DICOM Freedom of 21 CFR Part 11 The National Archive (TNA) Information Act of 2000 ISO US Patriot Act NARA Part 1234 FSA - SYSC BaFin Germany GLBA DoD esign Act ISO Common Criteria

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Electronic Records and Electronic Signatures (21 CFR Part 11)

Electronic Records and Electronic Signatures (21 CFR Part 11) Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003 Electronic Records and Electronic Signatures (21 CFR Part 11) Hans-Beat Jenny, SwissMedic, Basel

More information

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0) Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a

More information

Risk-based Approach to Part 11 and GxP Compliance

Risk-based Approach to Part 11 and GxP Compliance Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!

More information

Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application

Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application DRAFT GUIDANCE This guidance is being distributed for comment purposes only. Comments and suggestions regarding

More information

Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite

Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite A white paper discussing the compliant use of the Oracle Electronic Record, Electronic Signature (E-Records)

More information

Jean Guichard. Introduction to Good Process Record Management (GxP) #: Internet-WP Version: e1.00 /EN

Jean Guichard. Introduction to Good Process Record Management (GxP) #: Internet-WP Version: e1.00 /EN Jean Guichard White Paper Introduction to Good Process Record Management (GxP) #: Internet-WP Version: e1.00 /EN Introduction to Good Process Record Management (GxP) 2 / 6 Document History Version Date

More information

Library Guide: Active Pharmaceutical

Library Guide: Active Pharmaceutical Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the

More information

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017 CSV Inspection Readiness through Effective Document Control Eileen Cortes April 27, 2017 Agenda Background CSV Readiness CSV and Change Management Process Inspection Readiness Do s and Don ts Inspection

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

Computerised System Validation

Computerised System Validation Computerised System Validation Considerations for the Validation Lifecycle Paul Moody GMP Conference 12 th November 2014 Regulatory References EU GMP Annex 11 (2011) http://ec.europa.eu/health/files/eudralex/vol-4/annex11_01-2011_en.pdf

More information

Introduction to 21 CFR 11 - Good Electronic Records Management

Introduction to 21 CFR 11 - Good Electronic Records Management INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article Introduction to 21 CFR 11 - Good Electronic Records Management Pal Tapas Kumar* and Maity Subhasis NSHM Knowledge Campus,

More information

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY:

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: QUESTIONS TO ASK AND RESPONSIBILITIES TO DOCUMENT Heather Longden Boston Chapter Educational Meeting April 2018 About Waters Lab Informatics Separations

More information

Implementation Life-cycle SOP

Implementation Life-cycle SOP 1.0 Commercial in Confidence 11-Aug-2006 1 of 12 Implementation Life-cycle SOP Document No: H4_SOP_0100 Prepared by: David Brown Date: 11-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 11-Aug-2006

More information

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando GLP Computerized Systems Updates from OECD Guidance Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando 1 Validation EPA GLP Obligation Expectations of the EPA for Computers in GLP (40 CFR

More information

Guidance for Industry - Computerized Systems Used in Clinical Trials

Guidance for Industry - Computerized Systems Used in Clinical Trials Page 1 of 14 Regulatory Information Computerized Systems Used in Clinical Trials Guidance for Industry - Computerized Systems Used in Clinical Trials

More information

Risk-Based Approach to Software Quality and Validation

Risk-Based Approach to Software Quality and Validation Risk-Based Approach to Software Quality and Validation By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Risk

More information

Validation and Automated Validation

Validation and Automated Validation TOP INDUSTRY QUESTIONS Validation and Automated Validation 1 Table of Contents 03 04 07 10 13 16 19 INTRODUCTION SECTION 1 - Validation Standards How is validation defined under Title 21 CFR Part 11? What

More information

Compliance & Validation Validation of Software-as-a-Service (SaaS Solutions)

Compliance & Validation Validation of Software-as-a-Service (SaaS Solutions) www.arisglobal.com A White Paper Presented By ArisGlobal Compliance & Validation Validation of Software-as-a-Service (SaaS Solutions) ARIS GLOBAL CORPORATE HEADQUARTERS ArisGlobal, 1266 East Main Street,

More information

COMPUTERISED SYSTEMS

COMPUTERISED SYSTEMS ANNEX 11 COMPUTERISED SYSTEMS PRINCIPLE This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components

More information

UNIFI 1.5 : Simplifying Qualification and Validation June 2012

UNIFI 1.5 : Simplifying Qualification and Validation June 2012 UNIFI 1.5 : Simplifying Qualification and Validation June 2012 2011 Waters Corporation 1 Waters Regulated Bioanalysis System Solution Sample Preparation Solutions Best in class ACQUITY UPLC I-Class The

More information

Good Automated Manufacturing Practices (GAMP)

Good Automated Manufacturing Practices (GAMP) Good Automated Manufacturing Practices (GAMP) Klaus Krause, Amgen ISPE/GAMP Americas Steering Committee ISPE San Francisco/Bay Area Chapter Meeting, October 7, 2004 Presentation Overview I. GAMP - Organization

More information

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:

More information

Risk-Based Approach to SAS Program Validation

Risk-Based Approach to SAS Program Validation Paper FC04 Risk-Based Approach to SAS Program Validation Keith C. Benze SEC Associates, Inc. 3900 Paramount Parkway, Suite 150 South Morrisville, NC 27560 ABSTRACT SAS is widely used throughout the FDA

More information

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt Validation Services SESSION 14 Documentation Requirements and Management for Validation 30 March 2017 Frits Vogt fritsvogt@valserv.nl Content Documentation Requirements and Management for Validation I.

More information

The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies

The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies By Rob Sims, UL Compliance to Performance When Life Sciences companies

More information

Introduction and Key Concepts Study Group Session 1

Introduction and Key Concepts Study Group Session 1 Introduction and Key Concepts Study Group Session 1 PD hours/cdu: CH71563-01-2018 (3 hours each session) 2015, International Institute of Business Analysis (IIBA ). Permission is granted to IIBA Chapters

More information

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP May 1-3, 2012 Javits Center New York, NY Introduction to ISPE GUIDE: SCIENCE AND RISK-BASED APPROACH FOR THE DELIVERY OF FACILITIES, SYSTEMS, AND EQUIPMENT & Overview of Amgen s CQP Commissioning and Qualification

More information

Manufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance

Manufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance Manufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance Bob Mauger, Principal Validation Consultant Cork, April 3/4 2003 Agenda Business System Compliance Overview

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev05MAR15

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev05MAR15 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Building Management Systems (BMS)

Building Management Systems (BMS) This article presents practical riskbased advice regarding the implementation and management of computerized aspecis of a Building Management System. Reprinted from The Official Journal of ISPE PHARMACEUTICAL

More information

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum IT Compliance in the FDA Regulated Industry IT & Automation Forum November 13, 2007 Caribe Hilton, San Juan Puerto Rico Speaker: Mr. Juan O. Pérez, Principal Consultant joperez@fdcpr.com IT Responsibilities

More information

June Are You Prepared for Validation?

June Are You Prepared for Validation? June 2010 Are You Prepared for Validation? Are you prepared for validation? For industries that operate in regulated environments, validation of processes and systems is an important and required part

More information

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE 1. PURPOSE The purpose of this SOP is to define the minimum requirements for Computer Systems Validation (CSV) at (insert name of company

More information

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852 22 January 2009 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 SUBMISSION OF COMMENTS, DOCKET NO. FDA-2008-D-0559 Dear Sir or Madam:

More information

The long anticipated draft of the FDA s

The long anticipated draft of the FDA s This article provides an overview of the draft guidance, the key changes in relation to the 1987 guidance, and reviews its potential impact on the current industry approaches to science- and risk-based

More information

Understanding GxP Regulations for Healthcare

Understanding GxP Regulations for Healthcare Understanding GxP Regulations for Healthcare GxP Guidelines What is GxP? GxP is a collection of quality guidelines and regulations created to ensure that bio/pharmaceutical products are safe, meet their

More information

Quality Manual. Index

Quality Manual. Index This quality policy manual is for the use of, its Clients, Vendors, and the appropriate Regulatory Agencies. Unauthorized duplication or transfer to others is prohibited. Index Authorization... 3 Introduction...

More information

Testing 2. Testing: Agenda. for Systems Validation. Testing for Systems Validation CONCEPT HEIDELBERG

Testing 2. Testing: Agenda. for Systems Validation. Testing for Systems Validation CONCEPT HEIDELBERG CONCEPT HEIDELBERG GMP Compliance for January 16-17, 2003 at Istanbul, Turkey Testing for Systems Validation Dr.-Ing. Guenter Generlich guenter@generlich.de Testing 1 Testing: Agenda Techniques Principles

More information

Source Documents Elettronici: Criticità Applicative e approccio alla convalida. Paolo Morelli CEO - Arithmos

Source Documents Elettronici: Criticità Applicative e approccio alla convalida. Paolo Morelli CEO - Arithmos Source Documents Elettronici: Criticità Applicative e approccio alla convalida Paolo Morelli CEO - Arithmos Arithmos Overview Established in 2010 as the IT branch of CROS NT group IT solutions to optimize

More information

ASQ FD&C GMP Quality Conference

ASQ FD&C GMP Quality Conference ASQ FD&C GMP Quality Conference End User Testing for Performance Qualification of GXP/ Part 11 Systems Off The Shelf (OTS) Dr. Teri Stokes, GXP International, Concord, MA USA www. GXPInternational.com

More information

Introduction and Key Concepts Study Group Session 1

Introduction and Key Concepts Study Group Session 1 Introduction and Key Concepts Study Group Session 1 PDU: CH71563-04-2017 (3 hours) 2015, International Institute of Business Analysis (IIBA ). Permission is granted to IIBA Chapters to use and modify this

More information

ISPE GAMP, leading the way to Productive Compliance

ISPE GAMP, leading the way to Productive Compliance ISPE GAMP, leading the way to Productive Compliance AUTHOR: Chris Reid, Chair ISPE GAMP Europe As well as presenting ISPE GAMP principles and practices for effective regulatory compliance, this White Paper

More information

Chapter 1. Pharmaceutical Industry Overview

Chapter 1. Pharmaceutical Industry Overview Chapter 1 Pharmaceutical Industry Overview 1.1 Introduction 2 1.2 Regulations 2 1.2.1 Health Insurance Portability and Accountability Act 2 1.2.2 The Code of Federal Regulations 3 1.2.3 Guidance for Industry

More information

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Longe Sunday Anthony Head- Quality Assurance May & Baker Nigeria Plc. Pharmacentre, Ota, Nigeria eaglesconsult@gmail.com; Slonge@may-

More information

GCP Basics - refresher

GCP Basics - refresher p. 01 GCP Basics - refresher Agenda: p. 02 Brief History of GCP GCP Regulations Principles of ICH E6 Sponsor Responsibilities Computer Systems Common Compliance Issues Brief History of GCP 3 Brief History

More information

Validation Strategies for Equipment from Multiple Vendors

Validation Strategies for Equipment from Multiple Vendors Welcome to our E-Seminar: Validation Strategies for Equipment from Multiple Vendors Page 1 Content FDA guidelines and inspectional observations Validation & Qualification Approaches Instrument Qualification

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 08 April 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

Curriculum Vitae Dr. Joachim Schoch-Bösken. jsb-validierung Zwischen den Bächen 9 D Rheinfelden

Curriculum Vitae Dr. Joachim Schoch-Bösken. jsb-validierung Zwischen den Bächen 9 D Rheinfelden Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 176 42 60 85 72 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de

More information

Risk management concepts in the industry

Risk management concepts in the industry Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE November/December 2010, Vol. 30 No. 6 www.ispe.org Copyright ISPE 2010 This article discusses how the GAMP 5 quality risk management

More information

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS

GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 011-2 1 July 2004 PIC/S GUIDANCE GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS PIC/S July 2004

More information

Considerations for Using etools in Research: Part 11 and System Validation

Considerations for Using etools in Research: Part 11 and System Validation Considerations for Using etools in Research: Part 11 and System Validation Mitchell Parrish, JD, RAC, CIP, VP of Legal Affairs James Riddle, MCSE, CIP, CPIA, VP of Client Services 04/19/18 description

More information

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY TO and

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY  TO and 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org 31 October 2008 Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY EMAIL TO entr-gmp@ec.europa.eu

More information

Global Compliance Trends and Warning Letters

Global Compliance Trends and Warning Letters Contact: Charles Lu Director, Quality Carlsbad Tech Phone: (760) 431-8284 Fax: (203) 555-0101 5928 Farnsworth Ct Carlsbad, CA, 92008 www.carlsbadtech.com Global Compliance Trends and Warning Letters Governance

More information

21 CFR Part 11 and NetDimensions. Please note: McDowall Consulting is the source of much of the vertical specific domain information.

21 CFR Part 11 and NetDimensions. Please note: McDowall Consulting is the source of much of the vertical specific domain information. 21 CFR Part 11 and NetDimensions Please note: McDowall Consulting is the source of much of the vertical specific domain information. Agenda Background & Context Compliance & Quality Assurance What is 21

More information

Data Reliability - Internet

Data Reliability - Internet Data Reliability - Internet Wikipedia https://en.wikipedia.org/wiki/reliability_of_wikipedia Others http://www.dailymail.co.uk/health/article- 2639910/Do-NOT-try-diagnose-Wikipedia-90-medicalentries-inaccurate-say-expertsDo.html

More information

PLA 2.0. Software for Analyzing Parallel-Line and Parallel-Logistics Assays

PLA 2.0. Software for Analyzing Parallel-Line and Parallel-Logistics Assays PLA 2.0 Software for Analyzing Parallel-Line and Parallel-Logistics Assays Parallel-Line and Parallel-Logistics Assays Biological or potency assays are frequently analyzed with the help of the parallel-line

More information

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago

More information

Regulatory Expectations, Standards & Guidelines

Regulatory Expectations, Standards & Guidelines Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory

More information

Article from: CompAct. April 2013 Issue No. 47

Article from: CompAct. April 2013 Issue No. 47 Article from: CompAct April 2013 Issue No. 47 Overview of Programmatic Framework and Key Considerations Key elements Description Items to consider Definition and identification of EUCs The statement that

More information

PLA Product Overview. PLA 2.1 Overview

PLA Product Overview. PLA 2.1 Overview PLA 2.1 - Software For Biological Assays Product Overview PLA 2.1 Overview PARALLEL-LINE AND PARALLEL-LOGISTIC ASSAYS Parallel-Logistic Assay Biological or potency assays are frequently analyzed with the

More information

Discussion Paper on the Validation of Pharmacovigilance Software provided via SaaS

Discussion Paper on the Validation of Pharmacovigilance Software provided via SaaS Discussion Paper on the Validation of Pharmacovigilance Software provided via SaaS June 2012 K Edmonds Page 1 of 10 Page 2 of 10 Contents 1. Introduction... 4 2. Quality Statement ISO 9001:2015... 4 3.

More information

Software Quality Regulatory Trends

Software Quality Regulatory Trends Software Quality Regulatory Trends By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Software Quality Regulatory

More information

Infor CloudSuite Industrial

Infor CloudSuite Industrial Infor CloudSuite Industrial Stay current with the shifting standards of FDA compliance For medical device manufacturers, advancing and maintaining information management solutions that are compliant with

More information

Robbie Morehead Project Manager

Robbie Morehead Project Manager Profile The consultant is an accomplished quality professional with 27 years' extensive medical device, pharmaceutical, regulatory, and Food and Drug Administration (FDA) experience. The consultant s experience

More information

Whitepaper BMS and Process Historian Validation Strategy

Whitepaper BMS and Process Historian Validation Strategy Whitepaper BMS and Process Historian Validation Strategy I N D U S T R Y I N S I G H T S Norman A. Goldschmidt Principal, VP Engineering www.geieng.com I N D U S T R Y I N S I G H T S Genesis periodically

More information

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008)

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) Principle The introduction of computerised systems into systems of manufacturing, including storage,

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements

More information

21CFR11 Compliance and Automated Manufacturing

21CFR11 Compliance and Automated Manufacturing Presented at the World Batch Forum North American Conference Woodcliff Lake, NJ April 7-10, 2002 107 S. Southgate Drive Chandler, Arizona 85226-3222 480-893-8803 Fax 480-893-7775 E-mail: info@wbf.org www.wbf.org

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

21 CFR Part 11 Compliance

21 CFR Part 11 Compliance ENTERPRISE CONTENT MANAGEMENT ON THE MICROSOFT PLATFORM Table of Contents Page 1 Introduction Page 5-13 Electronic Record Compliance and FirstPoint Applicability Pages 14-18 Electronic Signature Compliance

More information

Deconstructing the EMA Reflection Paper

Deconstructing the EMA Reflection Paper Deconstructing the EMA Reflection Paper IRT2014 Christine Hurley Gibson Associate Director, Clinical Systems & Technology OBJECTIVES Share a bit of about how Biogen Idec approaches IRT management Review

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

TRICARE Operations Manual M, February 1, 2008 Records Management. Chapter 2 Section 1

TRICARE Operations Manual M, February 1, 2008 Records Management. Chapter 2 Section 1 Records Management Chapter 2 Section 1 1.0 POLICY 1.1 This chapter implements the Department of Defense (DoD) Records Management Policy, and Defense Health Agency (DHA) Records Retention Schedule (RRS)

More information

Design Qualification SOP

Design Qualification SOP 1.0 Commercial in Confidence 16-Aug-2006 1 of 13 Design Qualification SOP Document No: SOP_0400 Prepared by: David Brown Date: 16-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 16-Aug-2006 2 of 13

More information

PSM. Practical Software and Systems Measurement A foundation for objective project management. PSM TWG ISO/IEC and IEEE Standards.

PSM. Practical Software and Systems Measurement A foundation for objective project management. PSM TWG ISO/IEC and IEEE Standards. Practical Software and Systems Measurement A foundation for objective project management PSM PSM TWG ISO/IEC and IEEE Standards March 29, 2006 PSM 1 29 Mar 06 Current Standard Activities ISO/IEC 15939,

More information

OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use

OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use OECD Working Group on Good Laboratory Practice Template for submission of comments on draft GLP Guidance Documents Instructions for Use 1. First, please complete the table below giving the full name of

More information

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2 Introduction 1 The Requirements in Short 2 SIMATIC IT Meeting the Requirements with SIMATIC IT R&D Suite V7.1 3 SIMATIC IT R&D SUITE V7.1 Evaluation List for SIMATIC IT R&D Suite V7.1 4 Product Information

More information

Auditing Software Vendors

Auditing Software Vendors Auditing Software Vendors By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Auditing Software Vendors Copyright

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Developing a Robust Quality System to Assure Data Integrity

Developing a Robust Quality System to Assure Data Integrity Developing a Robust Quality System to Assure Data Integrity Maryann Gribbin Chief Compliance Officer, Faith & Royale Consultants Co-Chair PDA Data Integrity Task Force Data Integrity Facts or information

More information

Preventive Controls & cgmp s for Animal Food Industry Perspective Michele M. Evans, Ph.D. Diamond Pet Foods

Preventive Controls & cgmp s for Animal Food Industry Perspective Michele M. Evans, Ph.D. Diamond Pet Foods Preventive Controls & cgmp s for Animal Food Industry Perspective Michele M. Evans, Ph.D. Diamond Pet Foods November 3, 2015 Preventive Controls Mini Conference: Is Small Industry Exempt from FSMA Preventive

More information

World Journal of Pharmaceutical Research SJIF Impact Factor 5.990

World Journal of Pharmaceutical Research SJIF Impact Factor 5.990 SJIF Impact Factor 5.990 Volume 5, Issue 01, 1092-1134. Research Article ISSN 2277 7105 COMPUTER VALIDATION AND ETHICAL SECURITY MEASURES FOR PHARMACEUTICAL DATA PROCESSING Omprakash G. Bhusnure 1*, Kendre

More information

SharePoint Lifecycle Management. 31 May 2014

SharePoint Lifecycle Management. 31 May 2014 SharePoint Lifecycle Management 31 May 2014 About the Speaker Member of the Executive Team at Gimmal Helped found an RM company in Vancouver 25 Years Developing and Marketing Technology 20 year in Software

More information

ESG Impact Report. The effect on information management and the storage industry. Executive Summary. A research study by the Enterprise Storage Group

ESG Impact Report. The effect on information management and the storage industry. Executive Summary. A research study by the Enterprise Storage Group ESG Impact Report Compliance: The effect on information management and the storage industry Executive Summary A research study by the Enterprise Storage Group May 2003 Authors: Peter A. Gerr Brian Babineau

More information

ICH Q8/Q8(R)

ICH Q8/Q8(R) Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since

More information

Windchill Quality Management

Windchill Quality Management Windchill Quality Management Closed-Loop Quality for Medical Device Innovators Windchill Quality Management is purpose-built for medical device makers who seek to accelerate delivery of breakthrough medical

More information

Data Integrity Trends and How They Impact Validation. Erik Muegge, M.S., PMP Abbott Diagnostics Division IVT Dublin Validation Week 2016

Data Integrity Trends and How They Impact Validation. Erik Muegge, M.S., PMP Abbott Diagnostics Division IVT Dublin Validation Week 2016 Data Integrity Trends and How They Impact Validation Erik Muegge, M.S., PMP Abbott Diagnostics Division IVT Dublin Validation Week 2016 Agenda History what got us here Current thoughts from the FDA How

More information

Medidata Clinical Cloud (MCC) Validation

Medidata Clinical Cloud (MCC) Validation 1 Medidata Clinical Cloud (MCC) Validation Medidata develops, validates, installs, maintains and supports all components of Medidata s cloud-based, Software as a Service (SaaS) platform, i.e., the Medidata

More information

á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION

á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION First Supplement to USP 40 NF 35 General Information / á1058ñ Analytical Instrument Qualification 1 á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION INTRODUCTION A large variety of analytical instruments, ranging

More information

Water purification in the pharmaceutical industry

Water purification in the pharmaceutical industry ABB MEASUREMENT & ANALYTICS APPLICATION DESCRIPTION Water purification in the pharmaceutical industry Providing independent verification and validation of the water purification process for compliance

More information

How to support compliance with GAMP 5

How to support compliance with GAMP 5 PRESENTATION How to support compliance with GAMP 5 KERESZTESI Kálmán Controsys Irányítástechnikai Kft. kalman.keresztesi@controsys.hu Agenda What is GAMP 5 about? Application Lifecycle Management in automation

More information

As organizations use electronic signature solutions to

As organizations use electronic signature solutions to internal procedures to enforce accountability in processes not directly covered by laws and regulations. As we shall see in the following sections, some laws, regulations and business policies directly

More information

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1 AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences

More information

Quality Risk Management for Computerised Systems- A Review

Quality Risk Management for Computerised Systems- A Review International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.6, No.3, pp 915-919. July-Aug 2014 Quality Risk Management for Computerised Systems- A Review Sumanth T.N.*, M.N. Raviteja,

More information

Challenges in Implementing Knowledge Management within ICH Q10

Challenges in Implementing Knowledge Management within ICH Q10 Challenges in Implementing Knowledge Management within ICH Q10 SYMPOSIUM - New Frontiers in Manufacturing Technology, Regulatory - Brasilia Joseph C. Famulare Vice President, Global Head Compliance and

More information